• Infant Milk Formula (Source: Getty Images)
    Infant Milk Formula (Source: Getty Images)
Close×

The Chinese State Administration of Market Regulation (SAMR) has proposed five changes to the registration process of the country's infant formula milk powder, as it aims to boost product quality, scientific evidence and safe consumption.

The Administrative Measures for the Registration of Product Formulas of Infant Formula Milk Powder regulations were first introduced in 2016 and the SAMR is now seeking public consultation to the changes.

“There is a need to improve the means to a stricter registration process and clearly state the impermissible conditions,” the proposal said.

The five changes proposed include:

  1. Stricter registration criteria – approved applicants would need to “possess the entire production process” of the infant milk powder, as well as seven conditions as to whether an application is rejected, such as listed raw materials lack evidence in supporting safety behind the product.

  2. Heavier penalties for offenders – applicants blacklisted as an “enterprise with a serious breach of trust” will not be considered for product registration. Penalties would also apply to changes or renting out product registration certificates.

  3. Streamlining workflow – likely to also impact government administration bodies, and aims to simplify registration procedures, decentralise power and enhance supervision.

  4. Clearer job scope and timeline – outlining clearer job scopes, responsibilities and timelines for product inspection units.

  5. Change of department title – the deparment in charge of the product registration would change from China Food Drug Administration to the SAMR.

The changes follows the Chinese Government ministries joint action plan released in June to strengthen the domestic formula market, and is may have an impact on the recent supply deal between Chinese baby store chain Kidswant and Bubs Australia.

Packaging News

Pact Group will delist from the ASX on Wednesday 16 July, the move being the culmination of executive chair and owner Raphael Geminder’s near two-year bid to take full control of the company.

Packaging is at the heart of Suntory’s bold new chapter in Australia, marked by the opening of its $400 million beverage production facility in Swanbank, Queensland – a site purpose-built to deliver high-speed, high-efficiency bottling, canning and kegging through world-class packaging technology and sustainable design.

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.